Drug intelligence / Profile preview

Xiayuxue decoction

Development stage: Unknown
Modality: Small Molecules
Administration: Oral, Topical, Rectal

Overview

Xiayuxue decoction (XYXD) is a traditional Chinese medicine compound composed of three natural medicines: Rheum officinale Baill., Prunus persica (L.) Batsch, and Eupolyphaga sinensis Walker. It is derived from the ancient Chinese medical classic 'Jingui Yaolue' and has been utilized for thousands of years. XYXD is applied in the treatment of primary liver cancer, as outlined in the Guidelines for the Diagnosis and Treatment of Primary Liver Cancer issued by China's Health Commission. Its therapeutic action involves enhancing NKT cell-mediated immunity against hepatocellular carcinoma by promoting primary bile acid synthesis and improving gut microbiota.

Beyond the preview

Go deeper on Xiayuxue decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiayuxue decoction.

Explore the full profile